Market
BSE Prices delayed by 5 minutes... << Prices as on Jul 03, 2025 - 2:13PM >>  ABB India  5884.05 [ -0.31% ] ACC  1960 [ 1.07% ] Ambuja Cements  587.4 [ -1.19% ] Asian Paints Ltd.  2432.65 [ 0.53% ] Axis Bank Ltd.  1175 [ 0.00% ] Bajaj Auto  8421 [ 0.80% ] Bank of Baroda  243 [ 0.06% ] Bharti Airtel  2029.7 [ -0.14% ] Bharat Heavy Ele  258.95 [ -0.63% ] Bharat Petroleum  331.65 [ -0.08% ] Britannia Ind.  5820.5 [ 0.58% ] Cipla  1510.25 [ 0.87% ] Coal India  386.35 [ -0.14% ] Colgate Palm.  2445.95 [ 0.44% ] Dabur India  490.6 [ 0.65% ] DLF Ltd.  829.8 [ -0.24% ] Dr. Reddy's Labs  1290.25 [ 1.45% ] GAIL (India)  192.75 [ 1.02% ] Grasim Inds.  2829 [ -0.73% ] HCL Technologies  1714.8 [ -0.19% ] HDFC Bank  1995 [ 0.47% ] Hero MotoCorp  4314.75 [ 1.74% ] Hindustan Unilever L  2319.45 [ 0.54% ] Hindalco Indus.  696.3 [ -0.26% ] ICICI Bank  1428.55 [ 0.03% ] Indian Hotels Co  747.15 [ -1.18% ] IndusInd Bank  862.35 [ 0.49% ] Infosys L  1623.25 [ 0.83% ] ITC Ltd.  414.3 [ 0.34% ] Jindal St & Pwr  963.75 [ -0.54% ] Kotak Mahindra Bank  2127.5 [ -1.86% ] L&T  3605.5 [ 0.23% ] Lupin Ltd.  1944.6 [ -1.17% ] Mahi. & Mahi  3200 [ 1.12% ] Maruti Suzuki India  12775.9 [ 1.20% ] MTNL  51.18 [ -0.06% ] Nestle India  2393.75 [ 0.23% ] NIIT Ltd.  129.35 [ 0.66% ] NMDC Ltd.  68.9 [ 1.28% ] NTPC  334.25 [ 0.19% ] ONGC  244.2 [ 1.26% ] Punj. NationlBak  110.8 [ -2.68% ] Power Grid Corpo  294.2 [ -0.22% ] Reliance Inds.  1526.3 [ 0.53% ] SBI  810.4 [ -0.34% ] Vedanta  458.95 [ -2.27% ] Shipping Corpn.  222.15 [ -1.00% ] Sun Pharma.  1684.45 [ 0.39% ] Tata Chemicals  946.7 [ 1.32% ] Tata Consumer Produc  1094.05 [ -0.16% ] Tata Motors  694.2 [ 0.84% ] Tata Steel  166.95 [ 0.63% ] Tata Power Co.  400.1 [ -1.56% ] Tata Consultancy  3411.8 [ -0.34% ] Tech Mahindra  1677 [ 0.01% ] UltraTech Cement  12447.25 [ 0.08% ] United Spirits  1388.7 [ 0.38% ] Wipro  269.15 [ 0.82% ] Zee Entertainment En  142.25 [ 0.89% ] 
Nephro Care India Ltd. Notes to Accounts
Search Company 
You can view the entire text of Notes to accounts of the company for the latest year
Market Cap. (Rs.) 205.09 Cr. P/BV 3.87 Book Value (Rs.) 32.11
52 Week High/Low (Rs.) 379/116 FV/ML 10/400 P/E(X) 56.37
Bookclosure 20/09/2024 EPS (Rs.) 2.21 Div Yield (%) 0.00
Year End :2024-03 

d) Provisions, contingent liabilities and contingent assets: -Provisions

A provision is recognised when there is a present obligation as a result of a past event and it is probable that an outflow of resources will be required to settle the obligation and in respect of which reliable estimate can be made. Provisions are reviewed at each balance sheet date and adjusted to reflect the current best estimate. If it is no longer probable that an outflow of resources would be required to settle the obligation, the provision is reversed.

Contingent Liabilities

A disclosure for a contingent liability is made when there is a possible obligation or a present obligation but probably will not require an outflow of resources. When there is a possible obligation

or a present obligation in respect of which the likelihood on outflow of resources is remote, no provision or disclosure is made.

Contingent Assets

Contingent Assets are neither recognised nor disclosed. However, when realisation of the income is virtually certain, related asset is recognised.

Commitments

Commitments include the amount of the purchase order (net of advances) issued to the parties for completion of assets. Commitments are reviewed at each reporting period.

e) Revenue Recognition: -

The Company earns revenue primarily by providing income from OPD and sale of pharmaceutical products

Revenue is recognised upon transfer of control of promised products or services to customers in an amount that reflects the consideration which the Company expects to receive in exchange for those products or services. When there is uncertainty on ultimate collectability, revenue recognition is postponed until such uncertainty is resolved

Income from OPD

It consists of activities for physical examinations, treatments and tests and other fees The performance obligations for this stream of revenue include food & beverage, medical/clinical professional services and investigation

Pharmaceutical Products (Life Medicines)

Revenue from sale of pharmacy and pharmaceutical supplies is recognized at the point in time when control of the asset is transferred to the customer, generally on delivery of the pharmacy and pharmaceutical items. The Company collects goods and service tax (GST) on behalf of the government and, therefore, these are not economic benefits flowing to the Company and thus excluded from revenue. Revenue from the sale of goods is measured at the fair value of the consideration received or receivable, net of returns and allowances, trade discounts and volume rebates.

Interest Income

Interest income is recognised on time proportion basis taking into account the amount outstanding and interest rate applicable.

f) Inventories: -

Inventories comprises of pharmacy, drugs and consumables are valued at lower of cost or net realisable value. Cost includes cost of purchase, duties, taxes (other than those recoverable from tax authorities) and other cost bringing the inventories to their present location and condition.

Cost is determined First in First Out (FIFO) basis for medicine and other consumables Net Realisable Value represents the estimated selling price in the ordinary course of business less estimated costs necessary to make the sale

g) Employee Benefit Expenses: -

(a) Post Employee Benefits Gratuity

Gratuity is a post-employment benefit and is a defined benefit plan. The liability recognised in the balance sheet represents the present value of the defined benefit obligation at the balance sheet date, less the fair value of plan assets (if any), together with adjustment for unrecognised actuarial gains or losses and past service cost. Independent actuaries using the Projected Unit Credit Method calculate the defined benefit obligation annually. Actuarial gains or losses arising from experience adjustments and changes in actuarial assumptions are credited or charged to the statement of profit and loss in the year in which such gains or losses arises.

Provident Fund

The Company contributes to the statutory provident fund of the Regional Provident Fund Commissioner, in accordance with the Employees’ Provident Funds and Miscellaneous

Provisions Act, 1952 for its employees. The plan is a defined contribution plan and contribution paid or payable is recognised as an expense under the head 'Contribution to provident and other funds' in the period in which the employee renders services.

(b) Other long -term employment Benefits Leave Salary

The Company also provides benefit of leave salary under which un-availed leave are allowed to be accumulated to be availed in future. The scheme is considered as a long-term benefit. The liability for compensated absences is determined in accordance with the rules of the Company and is based on actuarial valuations made on projected unit method at the balance sheet date.

h) Foreign Currency Transaction: -

The financial statements are presented in Indian Rupee (INR) which is the functional and presentation currency of the company. Foreign currency transactions are translated into the functional currency using the spot rates of exchanges at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency spot rate of exchange at the reporting date. Foreign exchange gain and losses resulting from the settlement of such transaction and from the translation of monetary assets and liabilities are generally recognised in profit and loss in the year which they arise

i) Earnings Per Share: -

Basic earnings per equity share are calculated by dividing the net profit for the year attributable to equity shareholders by the weighted average number of equity shares outstanding during the year. For the purposes of diluted earnings per equity share, the net profit or loss for the year attributable to equity shareholders and the weighted average number of shares outstanding during the period are adjusted for the effects of all dilutive potential equity shares.

j) Event after reporting date: -

Where the events occurring after the Balance Sheet date provide evidence of conditions that existed at the end of the reporting period, the impact of such events adjusted within the financial statements. Otherwise, events after the Balance Sheet date of material size or nature are only disclosed

k) Segment Reporting: -

The Company identifies primary segments based on the dominant source, nature of risks and returns and the internal organisation and management structure. The operating segments are the segments for which separate financial information is available and for which operating profit/loss amounts are evaluated regularly by the executive Management in deciding how to allocate resources and in assessing performance. However the company is currently dealing in only one primary segment ie healthcare services

l) Borrowing Cost: -

Borrowing Cost includes interest and amortization of ancillary costs incurred in connection with the arrangement of borrowings. Borrowing costs directly attributable to the acquisition,

construction or production of an asset that necessarily takes a substantial period of time to get ready for its intended use or sale are capitalized as part of the cost of the respective asset. All other borrowing costs are expensed in the period they occur

m) Investments: -

Investments that are readily realisable and intended to be held for not more than a year are classified as current investments. All other investments are classified as long-term investments. Current investments are carried at lower of cost and fair value determined on an individual investment basis. Long-term investments are carried at cost.

Provision for diminution in value is made to recognise a decline other than temporary in the value of the long-term investments.

n) Cash and cash equivalents: -

Cash and cash equivalents comprise cash and deposit with banks. The Company considers all highly liquid investments at the time of purchase with a remaining maturity of three months or less and that are readily convertible to known amounts of cash to be cash equivalents.

o) Impairment: -

Management periodically assesses using external and internal sources where there is an indication that an asset may be impaired. Impairment occurs when the carrying value exceeds the present value of future cash flows expected to arise from the continuing use of the asset and its eventual disposal. The impairment loss to be recognised is determined as the excess of the carrying amount over the higher of asset's net selling price and present value as determined above. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is recorded only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined net of depreciation or amortisation, if no impairment loss has been recognised.

p) Lease: -

Leases of assets under which significant risks and rewards of ownership are effectively retained by the lessor are classified as operating leases. Lease payments under an operating lease are recognised as expense in the statement of profit and loss on a straight-line basis over the lease term.

Sd/-

Krishna Kumar Chanani

Partner, K K Chanani & Associates

Chartered Accountants

Membership No. 056045

FRN No. 322232E

UDIN No. 24056045BKBIIY3213

Kolkata, the 20th August, 2024


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by